PI3K: A Protein Involved in Cellular Signaling and Disease (P5954)

Target Name: Phosphatidylinositol 3-kinase (PI3K)

NCBI ID: P5954

Phosphatidylinositol 3-kinase (PI3K)

Other Name(s): PI3K | Phosphoinositide-3-kinase

PI3K: A Protein Involved in Cellular Signaling and Disease

Phosphatidylinositol 3-kinase (PI3K) is a protein that plays a crucial role in cellular signaling. It is a transmembrane protein that is involved in the phosphatidylinositol (phosphatidylinositol) signaling pathway. This pathway is involved in many cellular processes, including cell growth, differentiation, and survival. PI3K is a protein that is often targeted by drugs because of its role in cellular signaling.

PI3K is a protein that is composed of four transmembrane domains. It has a catalytic active site that is involved in the phosphorylation of the target protein. The catalytic active site is the site where the PI3K protein interacts with other proteins to cause the target protein to phosphorylize. This phosphorylation of the target protein can then trigger a cascade of downstream signaling pathways.

PI3K is a protein that is expressed in many different cell types, including neurons, muscle cells, and blood cells. It is also a protein that is involved in many different cellular processes, including cell growth, differentiation, and survival. For example, PI3K is involved in the regulation of cell growth and in the development of cancer. It is also involved in the regulation of muscle cell size and in the maintenance of muscle mass.

PI3K is a protein that has been targeted by many drugs as a potential drug target. For example, inhibitors of PI3K have been shown to be effective in treating a variety of diseases, including cancer, diabetes, and cardiovascular disease. These inhibitors work by inhibiting the activity of PI3K, which can lead to the inhibition of the signaling pathways that are controlled by PI3K.

In addition to its potential as a drug target, PI3K is also a protein that is often used as a biomarker. For example, the levels of PI3K have been shown to be elevated in certain types of cancer, which can be used as a biomarker for the disease. In addition, the activity of PI3K has been shown to be affected by various factors, including diet, exercise, and environmental factors. This makes PI3K a potential biomarker for the effects of these factors on cellular signaling.

Overall, PI3K is a protein that is involved in many cellular processes and has been shown to be involved in the regulation of many different diseases. As a result, it is a protein that is of interest as a potential drug target and as a biomarker. Further research is needed to fully understand the role of PI3K in cellular signaling and its potential as a drug and biomarker.

Protein Name: Phosphatidylinositol 3-kinase (PI3K) (nonspecified Subtype)

The "Phosphatidylinositol 3-kinase (PI3K) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Phosphatidylinositol 3-kinase (PI3K) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets